M
Masaaki Kawahara
Researcher at Osaka City University
Publications - 168
Citations - 9261
Masaaki Kawahara is an academic researcher from Osaka City University. The author has contributed to research in topics: Lung cancer & Survival rate. The author has an hindex of 46, co-authored 164 publications receiving 8765 citations.
Papers
More filters
Journal ArticleDOI
Phase III Study of Concurrent Versus Sequential Thoracic Radiotherapy in Combination With Mitomycin, Vindesine, and Cisplatin in Unresectable Stage III Non–Small-Cell Lung Cancer
Kiyoyuki Furuse,Masahiro Fukuoka,Masaaki Kawahara,Hideki Nishikawa,Y. Takada,Shinzoh Kudoh,Nobuyuki Katagami,Yutaka Ariyoshi +7 more
TL;DR: In selected patients with unresectable stage III NSCLC, the concurrent approach yields a significantly increased response rate and enhanced median survival duration when compared with the sequential approach.
Journal ArticleDOI
Irinotecan plus Cisplatin Compared with Etoposide plus Cisplatin for Extensive Small-Cell Lung Cancer
Kazumasa Noda,Yutaka Nishiwaki,Masaaki Kawahara,Shunichi Negoro,Takahiko Sugiura,A. Yokoyama,Masahiro Fukuoka,K. Mori,Koshiro Watanabe,Tomohide Tamura,Seiichiro Yamamoto,Nagahiro Saijo +11 more
TL;DR: Irinotecan plus cisplatin is an effective treatment for metastatic small-cell lung cancer and severe or life-threatening diarrhea was more frequent in the irinotican-plus-cisplatin group than in the etoposide-plus -cis Platin group.
Journal ArticleDOI
Phase III Study of Concurrent Versus Sequential Thoracic Radiotherapy in Combination With Cisplatin and Etoposide for Limited-Stage Small-Cell Lung Cancer: Results of the Japan Clinical Oncology Group Study 9104
Minoru Takada,Masahiro Fukuoka,Masaaki Kawahara,Takahiko Sugiura,A. Yokoyama,Soichiro Yokota,Yutaka Nishiwaki,Koshiro Watanabe,Kazumasa Noda,Tomohide Tamura,Haruhiko Fukuda,Nagahiro Saijo +11 more
TL;DR: This study strongly suggests that cisplatin plus etoposide and concurrent radiotherapy is more effective for the treatment of LS-SCLC than cisPlatin plus Etoposid and sequential radiotherapy.
Journal ArticleDOI
Pretreatment neutrophil count as an independent prognostic factor in advanced non-small-cell lung cancer: an analysis of Japan Multinational Trial Organisation LC00-03.
Satoshi Teramukai,Toshiyuki Kitano,Yusuke Kishida,Masaaki Kawahara,Kaoru Kubota,K Komuta,Koichi Minato,T. Mio,Yuka Fujita,Toshiro Yonei,Kikuo Nakano,Masahiro Tsuboi,Kazuhiko Shibata,Kiyoyuki Furuse,Masanori Fukushima +14 more
TL;DR: It is confirmed that pretreatment elevated neutrophil count is an independent prognostic factor in patients with advanced NSCLC receiving modern chemotherapy, and it may be a useful indicator of patient prognosis.
Journal ArticleDOI
Phase II clinical study of photodynamic therapy using mono-l-aspartyl chlorin e6 and diode laser for early superficial squamous cell carcinoma of the lung
Harubumi Kato,Kinya Furukawa,Masami Sato,Tetsuya Okunaka,Yohko Kusunoki,Masaaki Kawahara,Masahiro Fukuoka,Teruomi Miyazawa,Takashi Yana,Kaoru Matsui,Takeshi Shiraishi,Hirohisa Horinouchi +11 more
TL;DR: In this article, a phase II clinical study was conducted to investigate the anti-tumor effects and safety of NPe6 in patients with early superficial squamous cell carcinoma of the lung.